Product Information
MECLIZINE 25 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0777 per EA under NDC 16571066110. Its NADAC has been published 326 times since May 27, 2020.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AA.
The High Outlier badge above means this manufacturer's average price in the Meclizine Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
25 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571066110
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
MECLIZINE HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA010721FDA Approved
Before 1982
TE Code
AA
On Market Since
1/15/2020
Pharmacological Classes
Price Statistics
The NADAC for MECLIZINE 25 MG TABLET has been published 326 times since May 27, 2020, and over the history we have for it it has declined 54.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0777 per EA |
|---|---|
| All-time high | $0.1747 (Mar 10, 2021) |
| All-time low | $0.0705 (Nov 20, 2024) |
| 52-week high | $0.0845 |
| 52-week low | $0.0776 |
| Median price | $0.1048 |
| Average price | $0.1100 |
| Largest weekly change | -30.9% (Apr 17, 2024) |
| Weeks tracked | 326 |
| Tracking since | May 27, 2020 |
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 57% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MECLIZINE 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MECLIZINE 25 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0777 per EA (NDC 16571066110), effective Aug 19, 2026.
How has the price of MECLIZINE 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for MECLIZINE 25 MG TABLET has declined 54.0%. It has been tracked across 326 weekly CMS publications since May 27, 2020.
What are the highest and lowest recorded NADAC prices for MECLIZINE 25 MG TABLET?
Since May 27, 2020, the NADAC for MECLIZINE 25 MG TABLET has ranged from a low of $0.0705 (Nov 20, 2024) to a high of $0.1747 (Mar 10, 2021), with a median of $0.1048 per EA.
Are there cheaper alternatives to MECLIZINE 25 MG TABLET?
Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MECLIZINE 25 MG TABLET CHEW, is $0.0333 per EA — about 57% below MECLIZINE 25 MG TABLET.
Who manufactures MECLIZINE 25 MG TABLET?
MECLIZINE 25 MG TABLET (NDC 16571066110) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.